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The lipid sphingosine-1-phosphate has been identified as a key exit signal for lymph nodes. In this issue of
Immunity, Pham et al. (2008) show that its action can only be understood in the context of retention signals
transduced by CCR7.The molecular rules that control lympho-
cyte egress from lymph nodes are still
poorly understood compared to themulti-
step paradigm that controls entry through
high endothelial venules. The Cyster lab
has been leading the charge in studying
the role of the lipid sphingosine-1-phos-
phate (S1P) in this process, exploiting
T cells from S1P receptor-1 (S1P1)-defi-
cient mice, and in this issue of Immunity,
Pham et al. (2008) demonstrate that the
effects of S1P1 deficiency and pharmaco-
logical agents that target S1P1 are depen-
dent upon the amount of the homeostatic
chemokine receptor CCR7. These data
suggest a tug of war between S1P exit
signals and CCR7 ligand retention signals
for the attention of the T cell.
CCR7 is a chemokine receptor ex-
pressed on naive and central memory
T cells, and it is critical for efficient lym-
phocyte entry into secondary lymphoid
tissues through high endothelial venules
(Sallusto et al., 1999). CCR7 also contrib-
utes to the localization of T cells within
T cell zones and makes a quantitative
contribution to the speed of T cell migra-
tion within secondary lymphoid tissues,
but other Gi-linked G protein-coupled
receptors also contribute to this process,
based on experiments with pertussis-
toxin-treated T cells or mice (Okada and
Cyster, 2007). Here, Pham et al. (2008)
show that CCR7 also plays a critical role
in T cell retention within lymph nodes,
working in opposition to S1P exit signals.
They perform a side-by-side comparison
of wild-type and mutant T cell egress
in vivo by adoptive transfer and steady-
state experiments with the collection of
thoracic-duct lymph. T cells overexpress-ing CCR7 show a relative egress defect,
whereas cells lacking CCR7 egress more
rapidly. The most dramatic effect is that
CCR7 deficiency partially restores egress
in S1P1-deficient T cells, and treatment of
the T cells with pertusis toxin is evenmore
effective in restoring egress in the ab-
sence of S1P1. Treatment of mice with
the drug FTY720 largely phenocopies
the S1P1-deficient phenotype by downre-
gulating S1P1 on the T cells (Mandala
et al., 2002). Remarkably, CCR7-deficient
or pertussis-toxin-treated T cells show
restoration of egress in FTY720-treated
mice. Thus, exit through cortical sinu-
soids, at least, appears to be a default
T cell behavior in the absence of Gai-
mediated signaling. How this works phys-
ically is not entirely clear because pertus-
sis-toxin-treated T cells move very slowly
in the parenchyma (Okada and Cyster,
2007). Direct imaging of this process by
two-photon laser-scanning microscopy
will be interesting to see in the future,
but these experiments will need to have
better markers for tissue context (stroma,
lymphatics) because its clear that not
all cortical and paracortical regions are
equivalent.
Pham et al. (2008) interpret these re-
sults in terms of a direct competition or
a tug of war between CCR7 ligands, the
major one being CCL21, and S1P that
would be played out near the cortical
sinusoids. S1P is at high concentrations
in the blood and lymph and it is a chemo-
tactic agent for T cells via S1P1 coupling
to Gai, which would thus also be inhibited
by pertussis toxin. Stromal cells in the
T cell zones produce CCL21, as well as
CCL19, a second ligand for CCR7. TheImmunsuperficial paracortex regions immedi-
ately around high endothelial venules are
likely sites in which S1P and CCL21 gradi-
ents dovetail (Figure 1). The concept of
competing chemotactic signals has been
explored previously for neutrophils and
B cells responding to antigen. Hierarchies
of competing stop and go signals have
also been invoked in control of immuno-
logical-synapse formation during antigen
recognition (Dustin, 2004). However,
Pham et al. (2008) add new data to our
understanding of chemotactic control af-
ter antigen recognition. Specifically, they
show that after antigen-driven prolifera-
tion, effector T cells downregulate CCR7
and increase S1P1 expression, which
should favor egress through cortical sinu-
soids, based on their genetic data. This
process of egress to allow effector dis-
semination might be the key therapeutic
target of FTY720 and related drugs.
The authors demonstrate these effects
histologically in cortical sinusoids, an exit
compartment of lymph nodes that has
been largely overlooked, at least since
the 1970s. Most egress studies focus on
the medullary cords, which are closer to
the efferent lymphatics and are the place
where T cells accumulate in FTY720-
treated animals (Mandala et al., 2002);
however, the relative percentages of
T cell egress mediated by the cortical
sinusoids versus the medullary cords is
not known. In the lymph node, the sub-
capsular sinus, cortical sinusoids, and
themedullary cords are lined by lymphatic
endothelium. Because T cells are closer to
the cortical sinusoids in the steady state, it
is possible that much of the homeostatic
T cell egress takes place via the corticality 28, January 2008 ª2008 Elsevier Inc. 15
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Figure 1. Chemoattractant Gradients in Lymph Nodes
The schematic shows a three-compartment model for a lymph node, in which overplapping gradients of
chemokines CCL19 and CCL21 (green), CXCL13 (red), and CXCL12 (blue) define three parenchymal com-
partments, the deep paracortex, B cell follicles, and medullary cords, respectively. These chemokines are
captured on stromal cell surfaces but could also form gradients, particularly in boundary regions like those
around the cortical sinusoid exit sites. The cortical and medullary sinusoids are bounded by lymphatic en-
dothelial cells, which might have different properties. Pham et al. (2008) provide evidence for functional
S1P gradients that engage in a tug of war with CCL19and CCL21 gradients around cortical sinusoids (pur-
ple), which are always permissive for T cell exit, whereas Wei et al. (2005) provided evidence for control of
exit at medullary sinisoids, in which S1P1 signaling closed exit doors. This suggests the possibility that S1P
is not constitutively present at medullary cord exit sites but might be increased to prevent egress under
some conditions.sinusoids. The medullary cord paren-
chyma is occupied by plasma cells and
macrophages, and thus it is possible that
lymphatic endothelium in this region are
specialized for antibody transport and
might regulate cellular traffic in response
to innate immune signals from the macro-
phages to limit spread of infection.
Although this paper adds to the impres-
sive genetic data from the Cyster lab
demonstrating that S1P1 on T cells is crit-
ical for egress from lymph nodes, it still
does not explain the discrepancy with
data from Cahalan and colleagues in
explanted lymph nodes that clearly dem-
onstrates an important gate-keeper role
for medullary sinusoid endothelial cells in16 Immunity 28, January 2008 ª2008 Elseviecontrolling the egress of wild-type T cells
in an S1P1-dependent fashion (Wei
et al., 2005). The only hypothesis that
could bring these two stories together,
short of experimental artifacts with gene-
deficient T cells or explanted lymph
nodes, is that the gate-keeper roles of
cortical and medullary sinusoid edothelial
cells are differently programmed, as sug-
gested above. Intravital microscopy and
genetic studies dynamically dissecting
the different role of these two lymphatic
compartments will be important for the
full understanding of the mechanics and
biology of egress control in lymph nodes.
This is a complex problem in that there
are multiple molecular components thatr Inc.ct cooperatively in multiple compart-
ents to control egress. The output sig-
al—T cell in efferent lymph—is relatively
imited in resolution. Although direct im-
ging might provide some insights, the
igh-level complexity due to cooperative
ynamic events that span a wide range
f length scales (molecular receptor-
igand interactions to cell populations
n lymph nodes) makes intuition of the un-
erlying mechanisms difficult. Such prob-
ems in immunology can benefit from
ynergistic in vitro, in vivo, and in silico
tudies (Chakraborty et al., 2003). For
xample, one could begin by asking how
radients in different ligands (e.g., S1P,
CL21) and temporal patterns of receptor
xpression (e.g., S1P1, CCR7) control
gress. Models for random migration of
cells in lymphoid tissues (Beltman
t al., 2007) would have to be augmented
y the incorporation of chemotactic
otion and combined with models (or
easurements) that describe signaling
timulated by receptor-ligand binding.
computational model to examine the
eracity of the mechanism suggested by
he data reported by Pham et al. (2008)
ould be set up as follows. T cells move
n the paracortex via a default random
rocess that is biased by chemokine
radients and receptor expression. Upon
ncountering an egress portal (cortical si-
usoid), signals due to S1P1-S1P interac-
ions could dominate over signals due to
CR7-CCL21 interactions with a certain
robability, leading to egress. Theoretical
nd computational methods based on
angevin and Master equation ap-
roaches (Van Kampen, 1992) could
nterrogate such a model to understand
how the pertinent variables compete
to modulate egress versus retention, as
well as whether physiologically relevant
values of quantities (such as receptor
expression) can affect experimentally
observed outcomes. In addition to data
in Pham et al. (2008) and other studies
on response as a function of ligand
amount, such modeling efforts would
also require dose-response curves as
a function of receptor expression. This
type of data (or sophisticated signaling
models) is required for the determination
of the probability with which one type of
signal (e.g., stimulated by S1P1-S1P inter-
actions) can dominate over competing
ones. For the system examined by the
Cyster lab, such data could be obtained
Immunity
Previewsfrom in vitro studies. Synergy between
computational studies of increased so-
phistication, plus genetic and imaging
experiments, might shed light on mecha-
nistic principles that could then enable
an understanding of which factors deter-
mine the compliance or resistance of
gatekeeper lymphatic endothelium in dif-
ferent compartments.
Pham et al. (2008) adds two key
elements to future exit models. First, you
need to know the exits. Cortical sinusoids
appear well positioned to be the most
important exit sites for T cells. Second,
unlike the unidirectional paradigm for en-
try through high endothelial venules, exit
signals from tissue can only be appreci-
ated in the context of competing retentionsignals. Tissue T cells could often be held
in a tug of war between opposing signals
with shifting dominance, as responses
progress, underlying patterns of move-
ment. Identifying of the opposing teams
and how they are organized will be impor-
tant in advancing our understanding of
in vivo T cell function.
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